Search results - ORA - Oxford University Research Archive

« Previous | 1 - 10 of 11 | Next »

1

Journal article

Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/− cetuximab in oesophageal cancer

Crosby, T, Hurt, C, Falk, S, et al.
2017-02-14

2

Journal article

A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS

Gollins, S, West, N, Sebag-Montefiore, D, et al.
2019-08-17

3

Journal article

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer

Hurt, C, Falk, S, Crosby, A, et al.
2017-03-04

4

Journal article

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma

Mukherjee, S, Hurt, C, Gwynne, S, et al.
2017-02-08

5

Journal article

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

Seymour, M, Maughan, T, Ledermann, J, et al.
2007-07-01

6

Journal article

Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Macbeth, F, Griffiths, G, Noble, S, et al.
2009-09-01

7

Journal article

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.

Mukherjee, S, Hurt, C, Bridgewater, J, et al.
2013-04-01

8

Journal article

Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.

Crosby, T, Hurt, C, Falk, S, et al.
2013-06-01

9

Journal article

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.

Mukherjee, S, Hurt, C, Gwynne, S, et al.
2015-01-01

10

Journal article

NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma.

Mukherjee, S, Hurt, C, Gwynne, S, et al.
2015-12-01

TO TOP